Correlation Between Intracellular and Regencell Bioscience

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Intracellular and Regencell Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Intracellular and Regencell Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Intracellular Th and Regencell Bioscience Holdings, you can compare the effects of market volatilities on Intracellular and Regencell Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Intracellular with a short position of Regencell Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Intracellular and Regencell Bioscience.

Diversification Opportunities for Intracellular and Regencell Bioscience

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Intracellular and Regencell is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Intracellular Th and Regencell Bioscience Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Regencell Bioscience and Intracellular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Intracellular Th are associated (or correlated) with Regencell Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Regencell Bioscience has no effect on the direction of Intracellular i.e., Intracellular and Regencell Bioscience go up and down completely randomly.

Pair Corralation between Intracellular and Regencell Bioscience

Given the investment horizon of 90 days Intracellular is expected to generate 1.25 times less return on investment than Regencell Bioscience. But when comparing it to its historical volatility, Intracellular Th is 4.45 times less risky than Regencell Bioscience. It trades about 0.13 of its potential returns per unit of risk. Regencell Bioscience Holdings is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  655.00  in Regencell Bioscience Holdings on September 2, 2024 and sell it today you would lose (23.00) from holding Regencell Bioscience Holdings or give up 3.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Intracellular Th  vs.  Regencell Bioscience Holdings

 Performance 
       Timeline  
Intracellular Th 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Intracellular Th are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite fairly uncertain fundamental indicators, Intracellular demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Regencell Bioscience 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Regencell Bioscience Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile technical and fundamental indicators, Regencell Bioscience exhibited solid returns over the last few months and may actually be approaching a breakup point.

Intracellular and Regencell Bioscience Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Intracellular and Regencell Bioscience

The main advantage of trading using opposite Intracellular and Regencell Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Intracellular position performs unexpectedly, Regencell Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Regencell Bioscience will offset losses from the drop in Regencell Bioscience's long position.
The idea behind Intracellular Th and Regencell Bioscience Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas